Comments on: stage-specific impact of portal hypertension on outcomes after liver resection in hepatocellular carcinoma.
0/5 보강
APA
Peng Z, Liu Q (2026). Comments on: stage-specific impact of portal hypertension on outcomes after liver resection in hepatocellular carcinoma.. Hepatology international, 20(1), 194-195. https://doi.org/10.1007/s12072-025-10899-z
MLA
Peng Z, et al.. "Comments on: stage-specific impact of portal hypertension on outcomes after liver resection in hepatocellular carcinoma.." Hepatology international, vol. 20, no. 1, 2026, pp. 194-195.
PMID
40877527 ↗
같은 제1저자의 인용 많은 논문 (5)
- Neural Network Guided Global Least Squares for Quantitative Biochemical Component Analysis in Raman Spectroscopy.
- Blocking glycan production by targeting GALNT7 for prostate cancer therapy.
- PMM2 interacts with TRIM28 to recruit E2F4 and promote KIFC3-mediated tumor glycolysis and colorectal cancer progression.
- Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial.
- Trastuzumab deruxtecan in patients from China with previously treated human epidermal growth factor receptor 2-positive locally advanced/metastatic gastric or gastroesophageal junction adenocarcinoma (DESTINY-Gastric06): results from a single-arm, multicenter, phase 2 trial.